Medical News: ACR: Long-Term Biologic Use in RA Cuts MI, Cancer Risk - in Meeting Coverage, ACR from MedPage Today
Links shared publicly online about this topic.
- 0total visits
Medical News: ACR: Long-Term Biologic Use in RA Cuts MI, Cancer Risk - in Meeting Coverage, ACR from MedPage Today
CHICAGO -- Long-term treatment with the biologic agent etanercept (Enbrel) is not only effective against rheumatoid arthritis, but reduces the patient's risk of heart attack and malignancy, and may al
View full resource at medpagetoday.com
Tags: Cancer, Arthritis, Rheumatoid Arthritis, Rheumatoid Arthritis Medication, Enbrel, News, Medical
Most Recently Shared on November 13, 2011 at 5:08 pm By:
Long-Term Biologic Use in RA Cuts MI, Cancer Risk - #ACR2011 fhttp://bit.ly/sqjOP5 #rheum
Also Shared By:
Advertisement
Urology & Nephrology
@Urology_Wisdom
ACR: Long-Term Biologic Use in RA Cuts MI, Cancer Risk (CME/CE): CHICAGO (MedPage Today) -- Long-term treatment ... http://t.co/YT180J1O
1 year ago...